- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Japan, May 2013 (p30)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
- Global Data (708)
- Global Markets Direct (233)
- GBI Research (25)
- Business Monitor International (311)
- Global Research & Data Services (13)
-
- ICD Research (27)
- Canadean Ltd (12)
- Daedal Research (3)
- Global Industry Analysts (1)
- Datamonitor (159)
- Timely Data Resources Inc. (43)
- Espicom Business Intelligence (40)
- MarketLine (28)
- Global Industry Analyst (19)
- SCRIP Insights (17)
- Life Science Analytics (LSA) (15)
- VacZine Analytics Group Of Assay Advantage Ltd (15)
- Business Review (12)
- Euromonitor International (11)
- Visiongain (9)
- MarketLine Industry Guides (6)
- World Market Intelligence Ltd (6)
- Ken Research Private (5)
- Mintel (5)
- Frost & Sullivan (4)
- Infiniti Research Limited (4)
- Koncept Analytics (4)
- Pacific Bridge Medical (4)
- ABMRG (3)
- Aruvian's R'search (3)
- Currentpartnering (3)
- La Merie Publishing (3)
- Leatherhead Food Research (3)
- RNCOS (3)
- Obainfo (2)
- Barnes Reports (2)
- Kalorama Information (2)
- Renub Research (2)
- Urch Publishing (2)
- IData Research, Inc. (2)
- Arrowhead (1)
- BCC Research (1)
- Bioseeker (1)
- CCM International Limited (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- France Innovation Scientifique et Transfert (1)
- Greystone Research Associates (1)
- International Market Analysis Research and Consult (1)
- MarketsandMarkets (1)
- Pharmavision (1)
- Smart Research Insights (1)
- TriMark Publications (1)
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Japan, May 2013 (p30)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
871-910 of about 1 500 reports
Japan Poisonings, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 60-69 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 0-4 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 15-29 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 70+ Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 30-44 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 5-14 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, Total, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Geodon - Analysis and Forecasts from 2002 to 2017
- $ 2 000
- Industry report
- October 2011
- by Global Data
Geodon - Analysis and Forecasts from 2002 to 2017 Summary GlobalData's pharmaceuticals report, ?Geodon - Analysis and Forecasts from 2002 to 2017? provides Geodon sales estimates for US and EU5. In ...
- Industries : Pathology
- Countries : World, United States, Spain, Italy, France, Germany, Europe, United Kingdom, Japan
Eldepryl - Analysis and Estimates from 2002 to 2012
- $ 2 000
- Industry report
- October 2011
- by Global Data
Eldepryl - Analysis and Estimates from 2002 to 2012 Summary GlobalData's pharmaceuticals report, ?Eldepryl - Analysis and Estimates from 2002 to 2012? provides Eldepryl sales estimates for US, EU5 and ...
- Industries : Pathology
- Countries : Japan, United States, World, Spain, Italy, France, Germany, Europe, United Kingdom
Seroquel - Analysis and Estimates from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Seroquel - Analysis and Estimates from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Seroquel - Analysis and Estimates from 2002 to 2020? provides Seroquel sales estimates for US, EU5 and ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017
- $ 2 000
- Industry report
- October 2011
- by Global Data
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017 Summary GlobalData's pharmaceuticals report, ?Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017? provides Ventavis sales estimates ...
- Industries : Drug and Medication
- Countries : World, United States, Spain, Italy, France, Germany, Europe, United Kingdom, Japan
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020? provides Tracleer sales estimates ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Ramucirumab - Analysis and Market Forecasts from 2014 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Ramucirumab - Analysis and Market Forecasts from 2014 to 2020 Summary GlobalData's pharmaceuticals report, ?Ramucirumab - Analysis and Market Forecasts from 2014 to 2020? provides Ramucirumab sales estimates ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Gleevec - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Gleevec - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Gleevec - Analysis and Forecasts from 2013 to 2020? provides Gleevec sales estimates for US, EU5 and Japan. ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Doxorubicin - Analysis and Market Forecasts from 2011 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Doxorubicin - Analysis and Market Forecasts from 2011 to 2020 Summary GlobalData's pharmaceuticals report, ?Doxorubicin - Analysis and Market Forecasts from 2011 to 2020? provides Doxorubicin sales estimates ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Nexavar - Analysis and Market Forecasts from 2007 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Nexavar - Analysis and Market Forecasts from 2007 to 2020 Summary GlobalData's pharmaceuticals report, ?Nexavar - Analysis and Market Forecasts from 2007 to 2020? provides Nexavar sales estimates for US, ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
KW-6002- Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
KW-6002- Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?KW-6002- Analysis and Forecasts from 2013 to 2020? provides KW-6002 sales estimates for Japan. In addition, ...
- Industries : Pathology
- Countries : Japan
Mirapex ER - Analysis and Estimates from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Mirapex ER - Analysis and Estimates from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Mirapex ER - Analysis and Estimates from 2009 to 2020? provides Mirapex ERsales estimates for US and ...
- Industries : Pathology
- Countries : World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Zelapar - Analysis and Estimates from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Zelapar - Analysis and Estimates from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Zelapar - Analysis and Estimates from 2002 to 2020? provides Zelapar sales estimates for US, and UK. In ...
- Industries : Pathology
- Countries : United States, World, United Kingdom, Japan
Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- $ 3 500
- Company report
- October 2011
- by Global Data
Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, ?Atopic Dermatitis Therapeutics - Pipeline ...
- Industries : Therapy
- Countries : World, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Invega Sustenna - Analysis and Forecasts from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Invega Sustenna - Analysis and Forecasts from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Invega Sustenna - Analysis and Forecasts from 2009 to 2020? provides Invega Sustenna sales estimates ...
- Industries : Pathology
- Countries : World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Saphris - Analysis and Estimates from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Saphris - Analysis and Estimates from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Saphris - Analysis and Estimates from 2009 to 2020? provides Saphris sales estimates for US and Japan. ...
- Industries : Pathology
- Countries : Japan, United States, World
Seroquel XR - Analysis and Estimates from 2007 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Seroquel XR - Analysis and Estimates from 2007 to 2020 Summary GlobalData's pharmaceuticals report, ?Seroquel XR - Analysis and Estimates from 2007 to 2020? provides Seroquel XR sales estimates for US ...
- Industries : Pathology
- Countries : World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020? provides Tyvaso sales estimates ...
- Industries : Drug and Medication
- Countries : United States, World, Japan
RG1678 - Analysis and Forecasts from 2014 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
RG1678 - Analysis and Forecasts from 2014 to 2020 Summary GlobalData's pharmaceuticals report, ?RG1678 - Analysis and Forecasts from 2014 to 2020? provides RG1678 sales estimates for US, EU5 and ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Remodulin - Analysis and Forecasts from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Remodulin - Analysis and Forecasts from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Remodulin - Analysis and Forecasts from 2002 to 2020? provides Remodulin sales estimates for US, EU5 and ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Requip XL - Analysis and Estimates from 2007 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Requip XL - Analysis and Estimates from 2007 to 2020 Summary GlobalData's pharmaceuticals report, ?Requip XL - Analysis and Estimates from 2007 to 2020? provides Requip XL sales estimates for US and EU5 ...
- Industries : Pathology
- Countries : United States, World, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- $ 3 500
- Company report
- October 2011
- by Global Data
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, ?Rheumatoid Arthritis Therapeutics ...
- Industries : Therapy
- Countries : Japan, Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Riociguat - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Riociguat - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Riociguat - Analysis and Forecasts from 2013 to 2020? provides Riociguat sales estimates for US, EU5 and ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Miripla - Analysis and Market Forecasts from 2010 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Miripla - Analysis and Market Forecasts from 2010 to 2020 Summary GlobalData's pharmaceuticals report, ?Miripla - Analysis and Market Forecasts from 2010 to 2020? provides Miripla sales estimates for Japan. ...
- Industries : Pathology
- Countries : Japan
Stalevo - Analysis and Estimates from 2003 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Stalevo - Analysis and Estimates from 2003 to 2020 Summary GlobalData's pharmaceuticals report, ?Stalevo - Analysis and Estimates from 2003 to 2020? provides Stalevo sales estimates for US, EU5 and Japan. ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020
- $ 2 000
- Industry report
- September 2011
- by Global Data
Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, "Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020? provides Cisplatin sales forecasts ...
- Industries : Pathology
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020
- $ 2 000
- Industry report
- September 2011
- by Global Data
AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, "AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020? provides AMG 386 sales forecasts for the ...
- Industries : Pathology
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020
- $ 2 000
- Industry report
- September 2011
- by Global Data
Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, ?Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020? provides Votrient sales forecasts fo ...
- Industries : Pathology
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Carboplatin (Ovarian Cancer) - Analysis and Forecasts to 2020
- $ 2 000
- Industry report
- September 2011
- by Global Data
Carboplatin (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, "Carboplatin (Ovarian Cancer) - Analysis and Forecasts to 2020? provides Carboplatin sales forecasts ...
- Industries : Pathology
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020
- $ 2 000
- Industry report
- September 2011
- by Global Data
Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, ?Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020? provides Avastin sales forecasts for US, ...
- Industries : Pathology
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020
- $ 2 000
- Industry report
- September 2011
- by Global Data
EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, ?EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020? provides EC145 sales estimates for US, EU5 ...
- Industries : Pathology
- Countries : World, United States, Spain, Italy, France, Germany, Japan
» Download Public Reports
About 700 reports
Company Report: Pathology in The United States and Japan for Year 2013
- Company report
- January 2013
- 4 pages
- by Corporation
... Associated with juxtapid treatment may be a risk factor for progressive liver disease, including steatohepatitis and cirrhosis. Measure alt, ast, alkaline phosphatase, and total bilirubin before initiating ...
Intercell Ag - Investment Analysis, December 2012
December 2012Eisai Inc. - Annual Report 2012
December 2012Company Report: Pharmaceutical In Japan For Year 2013
February 2013The Japanese Pharmaceutical Industry Brief
February 2013» Read our Company Profiles
30 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomJohnson and Johnson
United StatesSanofi-Aventis Senegal
SenegalReportlinker.com © Copyright 2013. All rights reserved.
